Spironolactone Improved Children With NCOR Mutations

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

October 30, 2024

Primary Completion Date

October 30, 2025

Study Completion Date

October 30, 2025

Conditions
NCOR Gene MutationsSpironolactoneASD
Interventions
DRUG

.spironolactone

In the first week, the starting dose is 2mg/Kg per body weight once a day, taken with food at lunch every day, and subsequently adjusted according to the situation. If the patient's serum potassium is ≤5.0 mEq/L and the patient's serum creatinine is ≤2.5 mg/dL, treatment should be initiated with 25 mg spironolactone once daily. Increased to 100mg after remission. If the results are not obvious in the first month, increase the drug dose to 3mg/Kg.

All Listed Sponsors
lead

Qilu Hospital of Shandong University

OTHER

NCT06678685 - Spironolactone Improved Children With NCOR Mutations | Biotech Hunter | Biotech Hunter